The objective of the present project is to study deletions of the short arm of chromosone 9 found in human leukemia cell lines and in primary human leukemia cell samples. These deletions include the entire interferon gene cluster which is located at bands 9p21p22 and is composed of the beta interferon gene and about 30 alpha and alpha-like interferon genes and pseudogenes. These deletions are frequently submicroscopic in at least one chromosone 9 homologue. DNA sequences from inside the deleted regions, or surrounding them, will be cloned from genomic libraries enriched for very large restriction fragments that contain these sequences. These cloned DNA sequences will be used to map the deletion breakpoints and to examine their gene content. The breakpoint sequences will be cloned and analyzed to look for clues about the possible mechanism of deletion. As in the cases of retinoblastoma and Wilms' tumor, these deletions may result in the loss of a tumor suppressor gene or genes. Interferons have antiproliferative effects on various cell types. Since some of these effects are mediated by an autocrine mechanism, the interferon genes may be the tumor suppressor genes lost with the deletions of 9p. To test these hypotheses, the deleted chromosome region will be reintroduced into the """"""""deletion"""""""" cell lines by chromosome mediated gene transfer. In other experiments, cloned interferon genes will be transduced into the """"""""deletion"""""""" cell lines using retroviral vectors. The transfected or transduced cells will be compared to the original cell lines, with respect to their tumorigenicity in nude mice and growth properties in vitro. The effect of interferons on the growth of the """"""""deletion"""""""" cell lines also be studied. The proposed studies may be of relevance to biology of human leukemia, in revealing a new mechanism involved in leukemogenesis. This mechanism may be of importance in the initiation or progression of the disease, and it may have consequences for its diagnosis, prognosis and treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049133-02
Application #
3193094
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-01-13
Project End
1991-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Chaturvedi, V; Qin, J Z; Denning, M F et al. (1999) Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem 274:23358-67
Strissel, P L; Dann, H A; Pomykala, H M et al. (1998) Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9. Genomics 47:217-29
Pan, C; Xue, B H; Ellis, T M et al. (1997) Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 231:346-53
Jagasia, A A; Sher, D A; Le Moine, P J et al. (1996) Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells. Leukemia 10:624-8
Jagasia, A A; Block, J A; Diaz, M O et al. (1996) Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Lett 105:77-90
Larripa, I; Giere, I; Slavutsky, I et al. (1995) Molecular study of the interferon genes in chronic myeloid leukemia. Leuk Res 19:513-7
Bohlander, S K; Espinosa 3rd, R; Fernald, A A et al. (1994) Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet 65:108-10
Pomykala, H M; Bohlander, S K; Broeker, P L et al. (1994) Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol 14:7604-10
Colamonici, O R; Porterfield, B; Domanski, P et al. (1994) Ligand-independent anti-oncogenic activity of the alpha subunit of the type I interferon receptor. J Biol Chem 269:27275-9
Bohlander, S K; Dreyling, M H; Hagos, F et al. (1994) Mapping a putative tumor suppressor gene on chromosome 9 bands p21-p22 with microdissection probes. Genomics 24:211-7

Showing the most recent 10 out of 23 publications